Understanding Bladder Cancer Differences Between Men and Women
Sexual Dimorphism in Bladder Cancer
This project aims to discover why bladder cancer affects men more often and more severely than women, hoping to find new ways to treat it based on biological sex.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cedars-Sinai Medical Center NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-11134743 on NIH RePORTER |
What this research studies
Bladder cancer is much more common and deadly in men, even after accounting for lifestyle differences. Currently, treatments are similar for both sexes because we don't fully understand the biological reasons for this difference. This work explores how male hormones and a specific gene called KDM6A might create different biological environments in men and women, influencing how bladder cancer develops. By understanding these 'sex epigenome' differences, we hope to pave the way for more personalized and effective treatments.
Who could benefit from this research
Good fit: Patients with bladder cancer, particularly those interested in how biological sex influences disease development and treatment, are the focus of this foundational research.
Not a fit: Patients seeking immediate new treatments or direct clinical intervention will not find this basic science project directly beneficial in the short term.
Why it matters
Potential benefit: If successful, this work could lead to new, sex-specific treatments for bladder cancer that are more effective for men and women.
How similar studies have performed: While the observation of sex differences in bladder cancer is well-established, this specific mechanistic approach involving the 'sex epigenome' and KDM6A represents a novel direction.
Where this research is happening
Los Angeles, United States
- Cedars-Sinai Medical Center — Los Angeles, United States (Active)
Researchers
- Principal investigator: Li, Xue Sean — Cedars-Sinai Medical Center
- Study coordinator: Li, Xue Sean
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.